Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. TEM
TEM logo

TEM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Tempus AI Inc (TEM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
52.680
1 Day change
3.50%
52 Week Range
104.320
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Tempus AI Inc (TEM) is a good buy for a beginner investor with a long-term investment strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, significant partnerships, and leadership position in a growing market make it a compelling opportunity despite short-term market volatility. The recent price pullback provides an attractive entry point for long-term investors.

Technical Analysis

The stock's MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 43.964, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting short-term weakness. Key support is at $50, with resistance at $57.644. The stock is trading near its support level, which could provide a good entry point for long-term investors.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • Partnership with Merck to expand AI-driven precision medicine.

  • Strong revenue growth of 82.98% YoY in Q4

  • Leadership position in the precision oncology diagnostics market, which has a $40B TAM growing at 30% annually.

  • Hedge funds significantly increasing their positions, with an 884.13% increase in buying over the last quarter.

Neutral/Negative Catalysts

  • Broader market declines (S&P 500 down 0.97%).

  • Analysts have lowered price targets due to market volatility and valuation pullbacks.

  • Net income is still negative, though improving YoY.

Financial Performance

In Q4 2025, Tempus AI reported revenue growth of 82.98% YoY to $367.2M. Net income improved significantly by 316.21% YoY to -$54.17M. EPS also improved by 275% YoY to -$0.30. Gross margin increased to 64.73%, up 6.41% YoY. These metrics highlight strong operational growth and improving financial health.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed but leans positive. Recent ratings include several Buy/Outperform ratings with price targets ranging from $68 to $100. However, some analysts have expressed concerns about market volatility and valuation, leading to lowered price targets. The company's strong fundamentals and leadership position are consistently highlighted as positives.

Wall Street analysts forecast TEM stock price to rise
9 Analyst Rating
Wall Street analysts forecast TEM stock price to rise
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 50.900
sliders
Low
76
Averages
84.38
High
105
Current: 50.900
sliders
Low
76
Averages
84.38
High
105
H.C. Wainwright
Yi Chen
Buy
maintain
$89 -> $95
AI Analysis
2026-03-09
New
Reason
H.C. Wainwright
Yi Chen
Price Target
$89 -> $95
AI Analysis
2026-03-09
New
maintain
Buy
Reason
H.C. Wainwright analyst Yi Chen raised the firm's price target on Tempus AI (TEM) to $95 from $89 and keeps a Buy rating on the shares. Tempus AI continues to expand strategic partnerships, including collaborations with Merck (MRK), Median Technologies, and NYU Langone Health, to advance precision medicine, AI-driven diagnostics, and cancer research through its data platforms and molecular profiling capabilities, the analyst tells investors in a research note.
Morgan Stanley
Overweight
downgrade
$85 -> $70
2026-03-03
Reason
Morgan Stanley
Price Target
$85 -> $70
2026-03-03
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Tempus AI to $70 from $85 and keeps an Overweight rating on the shares. The firm updated its model following Q4 results.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TEM
Unlock Now

People Also Watch